Obserwuj
Marcos Serrano-Dueñas
Marcos Serrano-Dueñas
Zweryfikowany adres z puce.edu.ec
Tytuł
Cytowane przez
Cytowane przez
Rok
The international classification of headache disorders, (beta version)
Headache Classification Committee of the International Headache Society (IHS)
Cephalalgia 33 (9), 629-808, 2013
64672013
The international classification of headache disorders, (beta version)
DA Ettlin
Cephalalgia 33 (9), 629-808, 2013
4112013
Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale
P Martínez-Martín, C Rodríguez-Blázquez, M Alvarez, T Arakaki, VC Arillo, ...
Parkinsonism & related disorders 21 (1), 50-54, 2015
2292015
New diagnostic criteria for neurocysticercosis: reliability and validity
A Carpio, A Fleury, ML Romo, R Abraham, J Fandino, JC Durán, ...
Annals of neurology 80 (3), 434-442, 2016
1092016
Neuroleptic malignant syndrome-like, or—dopaminergic malignant syndrome—due to levodopa therapy withdrawal. Clinical features in 11 patients
M Serrano-Dueñas
Parkinsonism & related disorders 9 (3), 175-178, 2003
872003
Dementia associated with Parkinson’s disease: applying the Movement Disorder Society Task Force criteria
P Martinez-Martin, C Falup-Pecurariu, C Rodriguez-Blazquez, ...
Parkinsonism & related disorders 17 (8), 621-624, 2011
762011
Use of primidone in low doses (250 mg/day) versus high doses (750 mg/day) in the management of essential tremor. Double-blind comparative study with one-year follow-up
M Serrano-Dueñas
Parkinsonism & related disorders 10 (1), 29-33, 2003
522003
Chronic dopamimetic drug addiction and pathologic gambling in patients with Parkinson’s disease—presentation of four cases
M Serrano-Dueñas
German J Psychiatry 5, 62-66, 2002
482002
Effects of Banisteriopsis caapi extract on Parkinson’s disease
M Serrano-Dueñas, F Cardozo-Pelaez, JR Sánchez-Ramos
The Scientific Review of Alternative Medicine 5 (3), 127-132, 2001
482001
Two questionnaires for Parkinson’s disease: are the PDQ-39 and PDQL equivalent?
P Martinez-Martin, M Serrano-Duenas, MJ Forjaz, MS Serrano
Quality of Life Research 16, 1221-1230, 2007
472007
High altitude headache. A prospective study of its clinical characteristics
M Serrano-Duenas
Cephalalgia 25 (12), 1110-1116, 2005
472005
A comparison between low doses of amitriptyline and low doses of fluoxetin used in the control of depression in patients suffering from Parkinson's disease
M Serrano-Duenas
Revista de neurologia 35 (11), 1010-1014, 2002
472002
High-altitude headache
M Serrano-Dueñas
Expert Review of Neurotherapeutics 7 (3), 245-248, 2007
412007
Psychometric characteristics of the Parkinson's disease questionnaire (PDQ-39)—Ecuadorian version
P Martínez-Martín, M Serrano-Dueñas, V Vaca-Baquero
Parkinsonism & related disorders 11 (5), 297-304, 2005
332005
Validation and cross-cultural adjustment of PDQL-questionnaire, Spanish version (Ecuador)(PDQL-EV)
M Serrano-Dueñas, P Martı́nez-Martı́n, V Vaca-Baquero
Parkinsonism & related disorders 10 (7), 433-437, 2004
322004
A multicenter comparative study of impulse control disorder in Latin American patients with Parkinson disease
CCR Gómez, MS Dueñas, O Bernal, N Araoz, MS Farret, V Aldinio, ...
Clinical Neuropharmacology 40 (2), 51-55, 2017
292017
Analysis of four scales for global severity evaluation in Parkinson’s disease
npj Parkinson's Disease 2 (16007), 2016
292016
Delirium in Parkinson's disease patients. A five-year follow-up study
M Serrano-Dueñas, MJ Bleda
Parkinsonism & Related Disorders 11 (6), 387-392, 2005
272005
Influencing factors when living with Parkinson’s disease: A cross‐sectional study
L Ambrosio, MC Portillo, C Rodriguez‐Blazquez, JM Rojo, ...
Journal of Clinical Nursing 28 (17-18), 3168-3176, 2019
262019
Treatment of sialorrhea in Parkinson's disease patients with clonidine. Double-blind, comparative study with placebo
M Serrano-Duenas
Neurologia (Barcelona, Spain) 18 (1), 2-6, 2003
252003
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20